therapeutic autologous dendritic cells

Known as: ADC, autologous dendritic cells 
A population of a type of antigen-presenting cell (APC), the dendritic cell (DC), harvested from a patient and grown in vitro in the presence of… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1950-2017
05010019502016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
UNLABELLED This is a phase II clinical trial investigating the safety and efficacy of intravenous vaccination with mature… (More)
  • table 1
  • table 3
  • table 2
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
PURPOSE The aim of this work was to assess immunologic response, disease progression, and post-treatment survival of melanoma… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Measurements of tumor apparent diffusion coefficient (ADC), volume and diameter in assessing the response of patients with… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
PURPOSE The adoptive transfer of in vitro generated tumor antigen-specific cytotoxic T lymphocytes (CTL) provides a promising… (More)
  • table 1
  • figure 1
  • table 2
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
The cognate NK-DC interaction in inflamed tissues results in NK cell activation and acquisition of cytotoxicity against immature… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Polyvalent cancer vaccines targeting the entire antigenic spectrum on tumor cells may represent a superior therapeutic strategy… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
We attempted to induce therapeutic immunity against prostate-derived tissues in patients suffering from progressive hormone… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2000
Highly Cited
2000
PURPOSE Provenge (Dendreon Corp, Seattle, WA) is an immunotherapy product consisting of autologous dendritic cells loaded ex vivo… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
One approach to development of specific cancer immunotherapy relies on the induction of cytotoxic T lymphocytes (CTL) specific… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
BACKGROUND Conventional treatment for metastatic prostate cancer have failed to demonstrate curative potential in all patients… (More)
Is this relevant?